BLDpharm LOGO®
Keyword Search List Search Structure Search
| EN
Currency :
Choose your country/region & currency
  • Americas
    1. United States: USD
    2. Canada: USD
    3. Mexico: USD
    4. Brazil: USD
    5. All Others: USD
|
Cart 0
Home>Bulk Products>N-(Furan-2-ylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

About Us

Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.


With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.

Qualifications

ISO9001 ISO14001 ISO45001 Certified
DUNS: 560440352

BD314125[1073353-59-9]N-(Furan-2-ylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide*

Specific Information

Purity : 98% Specific Rotation :
NMR(H/C/F/S/P) : E.E. :
HPLC : Water Content :
Polymerization Inhibitor : Single Impurity :
Melting Point : Density :
Packaging : Solubility :
Name Note : Acetic Acid :
Beilstein : Grade :
Specific Gravity : Viscosity :
Others :
+86-21-61629022 sales@bldpharm.com Inquiry

Product Details

Cat No. : BD314125 Synonyms : N-(Furan-2-ylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
CAS No. : 1073353-59-9 MDL NO : MFCD09266168
Formule : C18H22BNO4 InChI Key : N/A
M.W : 327.18 Pubchem ID : 46739034
Boiling Point : No data available

Safety

Signal Word : Warning Class :
Precautionary Statements : P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501 UN# :
Hazard Statements : H315-H319-H335 Packing Group :
GHS Pictogram:

R&D Center